Hiroshi Iwamoto
- SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor growth and lung metastasis formation probably through the reduction of tumor angiogenesisBy Takeshi Masuda, Noboru Hattori, Kousuke Hamai, Shin Akita, Tadashi Senoo, Hiroshi Iwamoto, Shinichiro Ohshimo, Masashi Kanehara, Nobuhisa Ishikawa, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai and Nobuoki KohnoTakeshi MasudaMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanNoboru HattoriMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanKousuke HamaiMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanShin AkitaMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanTadashi SenooMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanHiroshi IwamotoMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanShinichiro OhshimoMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanMasashi KaneharaMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanNobuhisa IshikawaMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanKazunori FujitakaMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanYoshinori HarutaMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanHiroshi MuraiMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanNobuoki KohnoMolecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
- Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlapBy Hiroshi Iwamoto, Jing Gao, Jukka Koskela, Vuokko Kinnula, Hideo Kobayashi, Tarja Laitinen and Witold MazurHiroshi Iwamoto1Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki2Dept of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima6These authors contributed equally to this workJing Gao1Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki6These authors contributed equally to this workJukka Koskela3Dept of Medicine, University of Helsinki, HelsinkiVuokko Kinnula1Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, HelsinkiHideo Kobayashi4Dept of Pulmonary Medicine, National Defense Medical College, Tokorozawa, JapanTarja Laitinen5Dept of Pulmonary Diseases, Turku University Central Hospital, Turku, FinlandWitold Mazur1Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki
- Characteristics of inspiratory and expiratory reactance in interstitial lung diseaseBy Hiroshi Iwamoto, Noboru Hattori, Yoshinori Haruta, Aya Sugiyama, Izumi Nakamura, Misa Nakagawa, Shintaro Miyamoto, Yojiro Onari, Nobuhisa Ishikawa, Kazunori Fujitaka, Hiroshi Murai and Nobuoki KohnoHiroshi Iwamoto1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanNoboru Hattori1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanYoshinori Haruta1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanAya Sugiyama1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanIzumi Nakamura1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanMisa Nakagawa1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanShintaro Miyamoto1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanYojiro Onari1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanNobuhisa Ishikawa1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanKazunori Fujitaka1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanHiroshi Murai1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanNobuoki Kohno1Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
- KL-6 is a useful serum biomarker for early detection of interstitial lung diseaseBy Nobuoki Kohno, Nobuhisa Ishikawa, Naoko Deguchi, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai and Noboru HattoriNobuoki Kohno1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanNobuhisa Ishikawa1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanNaoko Deguchi1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanHiroshi Iwamoto1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanShinichiro Ohshimo1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanKazunori Fujitaka1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanYoshinori Haruta1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanHiroshi Murai1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanNoboru Hattori1Departments of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
- Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlapBy Hiroshi Iwamoto, Jing Gao, Jukka Koskela, Vuokko Kinnula, Hideo Kobayashi, Tarja Laitinen and Witold MazurArticle | Published in 2013 in European Respiratory JournalHiroshi Iwamoto*Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland#Dept of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanfThese authors contributed equally to this workJing Gao*Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki, FinlandfThese authors contributed equally to this workJukka Koskela¶Dept of Medicine, University of Helsinki, Helsinki, FinlandVuokko Kinnula*Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland**Dr. Vuokko Kinnula was affiliated with University of Helsinki and contributed substantially to the manuscript prior to her death on 17th November, 2012Hideo Kobayashi+Dept of Pulmonary Medicine, National Defense Medical College, Tokorozawa, JapanTarja Laitinen§Dept of Pulmonary Diseases, Turku University Central Hospital, Turku, FinlandWitold Mazur*Dept of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
- Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlapBy Hiroshi Iwamoto, Jing Gao, Jukka Koskela, Hideo Kobayashi, Tarja Laitinen and Witold MazurHiroshi Iwamoto1Department of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanJing Gao1Department of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki, FinlandJukka Koskela3Department of Medicine, University of Helsinki, Helsinki, FinlandHideo Kobayashi4Department of Pulmonary Medicine, National Defense Medical College, Tokorozawa, JapanTarja Laitinen5Department of Pulmonary Diseases, Turku University Central Hospital, Turku, FinlandWitold Mazur1Department of Medicine, Pulmonary Division, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
- Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumoniaBy Yasushi Horimasu, Nobuhisa Ishikawa, Taku Nakashima, Hiroshi Iwamoto, Tadashi Senoo, Shinichiro Ohshimo, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori and Nobuoki KohnoYasushi Horimasu1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanNobuhisa Ishikawa1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanTaku Nakashima1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanHiroshi Iwamoto1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanTadashi Senoo1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanShinichiro Ohshimo1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanKazunori Fujitaka1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanYoshinori Haruta1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanHiroshi Murai1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanNoboru Hattori1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, JapanNobuoki Kohno1Department of Molecular and Internal Medicine, Graduate School of BioMedical Science, Hiroshima University, Hiroshima, Japan
- Angiopoietin-2 gene polymorphism as prognostic factor in caucasians with idiopathic pulmonary fibrosisBy Shinichiro Ohshimo, Yasushi Horimasu, Francesco Bonella, Hiroshi Iwamoto, Nobuhisa Ishikawa, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Josune Guzman, Ulrich Costabel and Nobuoki KohnoShinichiro Ohshimo1Department of Emergency and Critical Care Medicine, Hiroshima University, Hiroshima, JapanYasushi Horimasu2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanFrancesco Bonella3Department of Pneumology/Allergy, Ruhrlandklinik, University Hospital, University Duisburg-Essen, Essen, GermanyHiroshi Iwamoto2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanNobuhisa Ishikawa2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanKazunori Fujitaka2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanYoshinori Haruta2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanHiroshi Murai2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanNoboru Hattori2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanNobuyuki Hirohashi1Department of Emergency and Critical Care Medicine, Hiroshima University, Hiroshima, JapanKoichi Tanigawa1Department of Emergency and Critical Care Medicine, Hiroshima University, Hiroshima, JapanJosune Guzman4General and Experimental Pathology, Ruhr-University, Bochum, GermanyUlrich Costabel3Department of Pneumology/Allergy, Ruhrlandklinik, University Hospital, University Duisburg-Essen, Essen, GermanyNobuoki Kohno2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, Japan
- Decreased circulatory receptor for advanced glycation end-products is associated with poorer survival in patients with idiopathic pulmonary fibrosisBy Hiroshi Iwamoto, Yasushi Horimasu, Taku Nakashima, Shinichiro Ohshimo, Nobuhisa Ishikawa, Kazunori Fujitaka, Yoshinori Haruta, Hiroshi Murai, Noboru Hattori, Witold Mazur and Nobuoki KohnoHiroshi Iwamoto1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanYasushi Horimasu1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanTaku Nakashima1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanShinichiro Ohshimo1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanNobuhisa Ishikawa1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanKazunori Fujitaka1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanYoshinori Haruta1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanHiroshi Murai1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanNoboru Hattori1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanWitold Mazur2Department of Medicine, University of Helsinki, Helsinki, FinlandNobuoki Kohno1Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, Japan
- Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adultsBy Keitaro Omori, Hiroshi Iwamoto, Noboru Hattori, Takashi Yamane, Taku Nakashima, Yoshinori Haruta, Akihito Yokoyama and Nobuoki KohnoKeitaro Omori1Molecular and Internal Medicine, Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, JapanHiroshi Iwamoto1Molecular and Internal Medicine, Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, JapanNoboru Hattori1Molecular and Internal Medicine, Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, JapanTakashi Yamane1Molecular and Internal Medicine, Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, JapanTaku Nakashima1Molecular and Internal Medicine, Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, JapanYoshinori Haruta1Molecular and Internal Medicine, Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, JapanAkihito Yokoyama2Hematology and Respiratory Medicine, Kochi University, Kohasu, Nankoku, Kochi, JapanNobuoki Kohno1Molecular and Internal Medicine, Biomedical & Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
- Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosisBy Shinichiro Ohshimo, Chihiro Yamaoka, Yasush Horimasu, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Francesco Bonella, Josune Guzman, Ulrich Costabel and Nobuoki KohnoShinichiro Ohshimo1Department of Emergency and Critical Care Medicine, Hiroshima University, Hiroshima, JapanChihiro Yamaoka2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanYasush Horimasu2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanHiroshi Iwamoto2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanKazunori Fujitaka2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanHironobu Hamada2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanNoboru Hattori2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, JapanNobuyuki Hirohashi1Department of Emergency and Critical Care Medicine, Hiroshima University, Hiroshima, JapanKoichi Tanigawa1Department of Emergency and Critical Care Medicine, Hiroshima University, Hiroshima, JapanFrancesco Bonella3Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University Duisburg-Essen, Essen, GermanyJosune Guzman4General and Experimental Pathology, Ruhr University, Bochum, GermanyUlrich Costabel3Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University Duisburg-Essen, Essen, GermanyNobuoki Kohno2Department of Molecular and Internal Medicine, Hiroshima University, Hiroshima, Japan
- MUC1 gene polymorphism and serum KL-6 in lung adenocarcinomaBy Yasushi Horimasu, Nobuhisa Ishikawa, Sonosuke Tanaka, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Noboru Hattori, Hironobu Hamada and Nobuoki KohnoYasushi Horimasu1Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanNobuhisa Ishikawa2Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima, JapanSonosuke Tanaka3Department of Internal Medicine, Saijo City Hospital, Shobara, JapanHiroshi Iwamoto1Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanShinichiro Ohshimo1Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanKazunori Fujitaka1Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanNoboru Hattori1Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanHironobu Hamada4Department of Physical Analysis and Therapeutic Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanNobuoki Kohno1Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.